AgingResearch.NewsJoin free

Empagliflozin + adipose-derived mesenchymal stem cells

Intervention

1 paper studies it1 finding

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab in 1 country
  • Funders: Chang Gung Medical Foundation and 2 more
  • Animals1

Outcomes

1

Thermal paw-withdrawal latency

upin rats1

1 study

  1. Empagliflozin + adipose-derived mesenchymal stem cells improve thermal paw-withdrawal latency in rats (P<0.0001).

    “values of thermal paw-withdrawal-latency (TPWL)/mechanical-paw-withdrawal-threshold were highest in group 1 and significantly progressively increased from groups 2/4/3/5 (all P<0.0001)”

    Animalsin diabetic neuropathy (group 5 vs 2/4/3)6 weeks

    Addition of adipose tissue-derived mesenchymal stem cells improves empagliflozin therapy for alleviating hyperglycemia--induced neuropathy

    American journal of translational researchOct 15, 2023

Latest

Related